Sequencing bispecific antibodies and CAR T cell therapy in multiple myeloma with prior exposure to BCMA-targeted therapies.

被引：0
|
作者：
Patel, Urvi
Oluwole, Olalekan O.
Kassim, Adetola
Jayani, Reena
Belliveau, Paul
Savani, Bipin
Dholaria, Bhagirathbhai R.
机构：
[1] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[3] Massachusetts Coll Pharm & Hlth Sci, Worcester, MA USA
[4] Vanderbilt Ingram Canc Ctr, Div Hematol & Oncol, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20049
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Comparative Analysis of Infectious Complications in Patients with Multiple Myeloma Treated with BCMA-Targeted Bispecific Antibodies and CAR T-Cell Therapy
    Nath, Karthik
    Shekarkhand, Tala
    Costa, Bruno Almeida
    Nemirovsky, David
    Derkach, Andriy
    Nishimura, Noriko
    Farzana, Tasmin
    Rueda, Colin
    Chung, David
    Landau, Heather
    Lahoud, Oscar Boutros
    Scordo, Michael
    Shah, Gunjan L.
    Hassoun, Hani
    Maclachlan, Kylee H.
    Korde, Neha
    Shah, Urvi A.
    Tan, Carlyn Rose
    Hultcrantz, Malin
    Giralt, Sergio A.
    Usmani, Saad Z.
    Shahid, Zainab
    Mailankody, Sham
    Lesokhin, Alexander
    BLOOD, 2023, 142
  • [2] A BCMA-TARGETED BISPECIFIC ANTIBODY IS ACTIVE IN MULTIPLE MYELOMA
    不详
    CANCER DISCOVERY, 2021, 11 (10) : 2366 - 2366
  • [3] Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma
    Reyes, Kevin R.
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    BLOOD, 2022, 140 : 5105 - 5107
  • [4] Efficacy and safety of BCMA-targeted CAR-T therapy in elderly patients with multiple myeloma
    Reyes, Kevin
    Huang, Chiung-Yu
    Lo, Mimi
    Arora, Shagun
    Chung, Alfred
    Wong, Sandy
    Wolf, Jeffrey
    Martin, Thomas
    Shah, Nina
    Banerjee, Rahul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S5 - S5
  • [5] Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma
    Fandrei, David
    Seiffert, Sabine
    Rade, Michael
    Rieprecht, Susanne
    Gagelmann, Nico
    Born, Patrick
    Wiemers, Thomas
    Weidner, Heike
    Kreuz, Markus
    Schassberger, Tamara
    Kossmann, Jannik
    Mangold, Marlene
    Fuerst, Daniel
    Fischer, Luise
    Baber, Ronny
    Heyn, Simone
    Wang, Song Yau
    Bach, Enrica
    Hoffmann, Sandra
    Metzeler, Klaus H.
    Herling, Marco
    Jentzsch, Madlen
    Franke, Georg-Nikolaus
    Koehl, Ulrike
    Friedrich, Maik
    Boldt, Andreas
    Reiche, Kristin
    Platzbecker, Uwe
    Vucinic, Vladan
    Merz, Maximilian
    BLOOD CANCER DISCOVERY, 2025, 6 (01): : 38 - 54
  • [6] BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy
    Paul, Barry
    Rodriguez, Cesar
    Usmani, Saad Z.
    DRUGS, 2022, 82 (06) : 613 - 631
  • [7] BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy
    Barry Paul
    Cesar Rodriguez
    Saad Z. Usmani
    Drugs, 2022, 82 : 613 - 631
  • [8] BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease
    Bucci, Laura
    Hagen, Melanie
    Boeltz, Sebastian
    Noethling, Danae-Mona
    Rothe, Tobias
    Raimondo, Maria Gabriella
    Tur, Carlo
    Wirsching, Andreas
    Wacker, Jochen
    Bozec, Aline
    Schett, Georg
    Grieshaber-Bouyer, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5403 - 5405
  • [9] Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy
    Van Oekelen, Oliver
    Mouhieddine, Tarek
    Pan, Darren
    Metzger, Megan
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David
    Lancman, Guido
    Lagana, Alessandro
    Richard, Shambavi
    Sanchez, Larysa
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S38 - S38
  • [10] Clinical Outcomes and Salvage Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Progression on BCMA-Targeted CAR-T Therapy
    Reyes, Kevin R.
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Shah, Nina
    Wong, Sandy W.
    Wolf, Jeffrey L.
    Arora, Shagun
    Chung, Alfred
    BLOOD, 2022, 140
12345